Casdin Capital’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-44,129
| Closed | -$373K | – | 38 |
|
|
2024
Q2 | $373K | Sell |
44,129
-1
| -0% | -$8 | 0.03% | 37 |
|
|
2024
Q1 | $681K | Hold |
44,130
| – | – | 0.05% | 35 |
|
|
2023
Q4 | $609K | Hold |
44,130
| – | – | 0.06% | 35 |
|
|
2023
Q3 | $504K | Sell |
44,130
-727
| -2% | -$8.31K | 0.06% | 36 |
|
|
2023
Q2 | $1.12M | Hold |
44,857
| – | – | 0.1% | 37 |
|
|
2023
Q1 | $1.63M | Hold |
44,857
| – | – | 0.13% | 36 |
|
|
2022
Q4 | $2.7M | Hold |
44,857
| – | – | 0.21% | 40 |
|
|
2022
Q3 | $3.36M | Buy |
44,857
+16,000
| +55% | +$1.2M | 0.22% | 30 |
|
|
2022
Q2 | $3.31M | Sell |
28,857
-19,239
| -40% | -$2.2M | 0.28% | 34 |
|
|
2022
Q1 | $9.11M | Hold |
48,096
| – | – | 0.41% | 37 |
|
|
2021
Q4 | $16.7M | Sell |
48,096
-41,666
| -46% | -$14.5M | 0.47% | 39 |
|
|
2021
Q3 | $30.1M | Hold |
89,762
| – | – | 0.75% | 33 |
|
|
2021
Q2 | $74M | Buy |
+89,762
| New | +$74M | 1.88% | 17 |
|